e-learning
resources
Berlin 2008
Monday, 06.10.2008
Understanding allergic airway inflammation with the help of animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice
S. Tsumura, E. Goto, R. Tanaka, K. Ito, K. Kojima, K. Nakamura, J. Hamamoto, K. Fujii, N. Saita, H. Kohrogi (Kumamoto, Japan)
Source:
Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Session:
Understanding allergic airway inflammation with the help of animal models
Session type:
Thematic Poster Session
Number:
2027
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Tsumura, E. Goto, R. Tanaka, K. Ito, K. Kojima, K. Nakamura, J. Hamamoto, K. Fujii, N. Saita, H. Kohrogi (Kumamoto, Japan). Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice. Eur Respir J 2008; 32: Suppl. 52, 2027
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Involvement of NK1, 2 and 3 receptors on antigen-induced airway hyperresponsiveness and inflammation induced in guinea-pigs
Source: Eur Respir J 2001; 18: Suppl. 33, 246s
Year: 2001
Absence of proton-sensing TDAG8 protects against ovalbumin-induced allergic airway inflammation
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4?
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
CCL6 produced by eosinophils drives allergic airway inflammation in mice
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
The activation of transient receptor potential melastatin 8 (TRPM8) receptors of bronchial epithelial cells induces airway inflammation in bronchial asthma
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
The serotoninergic receptor subtype 5-HTR1B contributes to the pathogenesis of allergic airway inflammation
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
5,6,7-Trihydroxy-4´-methoxy-flavanone from
Baccharis retusa
(asteraceae) attenuates allergen-induced airway inflammation and hyperresponsiveness in mice
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Role of complement receptor-related gene y (Crry)-Ig in allergic airway inflammation and hyperresponsiveness
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
The purinergic receptor P2Y2 mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
The muscarinic M
3
receptor regulates allergen-induced airway remodeling in mice
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
P-selectin expression in chronic allergic airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept